{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-24-021990","form_type":"8-K/A","ticker":"TVGN","cik":"0001860871","company_name":"Tevogen Bio Holdings Inc.","filed_at":"2024-05-30T23:59:59+00:00","discovered_at":"2026-05-14T18:03:20.947255+00:00","generated_at":"2026-06-01T07:28:49.896457+00:00","sec_items":["9.01"],"event_type":"other_material","sentiment":"negative","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"Tevogen Bio Inc reports 2023 net loss of $60.5M; cash only $1.05M, going concern raised","bullets":["Net loss of $60.5M in 2023 ($2.44/share) vs $22.0M in 2022; no revenue.","Operating expenses $8.8M; $50.4M non-cash loss from change in fair value of convertible notes.","Accumulated deficit $99.7M; cash $1.05M at Dec 31, 2023.","Auditors express substantial doubt about ability to continue as going concern.","Post-balance sheet: $2M Series A Preferred (Feb 2024) and $1.2M Series A-1 Preferred."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-24-021990","json":"https://secwatch.observer/filing/0001493152-24-021990.json","markdown":"https://secwatch.observer/filing/0001493152-24-021990.md","text":"https://secwatch.observer/filing/0001493152-24-021990.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1860871/000149315224021990/0001493152-24-021990-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1860871/000149315224021990/form8-ka.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-01T07:28:49.896457+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}